Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum.

Let's take a closer look at five of this past week's biggest scorchers.


July 13 Weekly Gain My Watchlist
Amerigroup (NYSE: AGP  ) $89.95 40% Add
Affymax (Nasdaq: AFFY  ) $16.49 30% Add
Orexigen Therapeutics (Nasdaq: OREX  ) $7.06 22% Add
Complete Genomics (Nasdaq: GNOM  ) $2.44 18% Add
SkyWest (Nasdaq: SKYW  ) $7.96 14% Add

Source: Barron's.

Amerigroup was the picture of health, soaring nearly 40% after WellPoint struck a deal to acquire the Medicaid coverage specialist. The all-cash deal will take Amerigroup shareholders out at $92, a healthy premium to where the stock was just before the deal was announced.

Affymax was one of the market's biggest winners after a company announced that it would be rolling out Affymax's anemia drug Omontys -- a drug that boosts red blood cell production for dialysis patients -- in at least 100 dialysis centers.

Orexigen shares fattened up after the company reported strong enrollment for its diet-drug study. The heavy demand now finds Orexigen targeting interim analysis of the study concluding by early next year, a lot earlier than original expectations.

Complete Genomics was DNA -- as in Deserving Notable Appreciation -- after introducing a new technology that can potentially set the new standard for clinical-grade genomes.

Regional air carrier SkyWest took off after placing an order with Mitsubishi for 100 jets.

More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.

The Motley Fool owns shares of WellPoint. Motley Fool newsletter services have recommended buying shares of WellPoint and Amerigroup. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1944543, ~/Articles/ArticleHandler.aspx, 10/22/2016 6:03:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 20 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 2:51 PM
AFFY $0.08 Down +0.00 +0.00%
Affymax, Inc. CAPS Rating: **
AGP.DL2 $91.70 Down +0.00 +0.00%
Amerigroup CAPS Rating: ****
GNOM.DL $0.00 Down +0.00 +0.00%
Complete Genomics CAPS Rating: **
OREX $2.82 Up +0.04 +1.44%
Orexigen Therapeut… CAPS Rating: *
SKYW $30.10 Down -0.10 -0.33%
SkyWest CAPS Rating: ***